Advertisement

Ads Placeholder
Loading...

Integra LifeSciences Holdings Corporation

IART•NASDAQ
Healthcare
Medical - Devices
$9.53
$-0.04(-0.42%)
U.S. Market opens in 20h 6m

Integra LifeSciences Holdings Corporation (IART) Stock Overview

Explore Integra LifeSciences Holdings Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap742.7M
P/E Ratio-1.42
EPS (TTM)$-6.74
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$6.47
3 Months$3.09
1 Year Target$1.58

IART Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Integra LifeSciences Holdings Corporation (IART) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.42 and a market capitalization of 742.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.42%
5-Day Change
1.60%
1-Month Change
-9.75%
3-Month Change
-20.65%
6-Month Change
-35.61%
Year-to-Date (YTD) Change
-20.65%
1-Year Change
-52.49%
3-Year Change
-83.24%
5-Year Change
-86.05%
All-Time (Max) Change
106.05%

Contact Information

https://www.integralife.com
609 275 0500
1100 Campus Road, Princeton, NJ, 08540

Company Facts

43,960 Employees
IPO DateAug 16, 1995
CountryUS
Actively Trading

Frequently Asked Questions